GetTopicDetailResponse(id=c2f4e76662a, topicName=組織化學(xué), introduction=組織化學(xué), content=null, image=null, comments=3, allHits=705, url=https://h5.medsci.cn/topic?id=77666, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=41323, tagList=[TagDto(tagId=41323, tagName=組織化學(xué))], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1804839, encodeId=3a70180483968, content=<a href='/topic/show?id=c2f4e76662a' target=_blank style='color:#2F92EE;'>#組織化學(xué)#</a>, objectTitle=肝硬化受試者肺血管的免疫組織化學(xué)特征和肺血管疾病的組織病理學(xué)證據(jù)：尸檢研究, objectType=article, longId=739319, objectId=7b82e39319b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b82e39319b8, replyNumber=0, likeNumber=91, createdTime=2023-08-21, rootId=0, userName=醫(yī)生2394, userId=b505306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b82e39319b8, moduleTitle=肝硬化受試者肺血管的免疫組織化學(xué)特征和肺血管疾病的組織病理學(xué)證據(jù)：尸檢研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7b82e39319b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804838, encodeId=4bda1804838e2, content=<a href='/topic/show?id=c2f4e76662a' target=_blank style='color:#2F92EE;'>#組織化學(xué)#</a>, objectTitle=J Cell Mol Med：肝組織免疫組織化學(xué)檢測HBcAg(-)是抗病毒治療的預(yù)測指標, objectType=article, longId=122583, objectId=10dc122583e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10dc122583e8, replyNumber=0, likeNumber=95, createdTime=2018-10-18, rootId=0, userName=醫(yī)生2394, userId=b505306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10dc122583e8, moduleTitle=J Cell Mol Med：肝組織免疫組織化學(xué)檢測HBcAg(-)是抗病毒治療的預(yù)測指標, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=10dc122583e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1804837, encodeId=f957180483e51, content=<a href='/topic/show?id=c2f4e76662a' target=_blank style='color:#2F92EE;'>#組織化學(xué)#</a>, objectTitle=肝母細胞瘤新輔助化療方案的治療效應(yīng)：形態(tài)學(xué)和免疫組織化學(xué)研究, objectType=article, longId=2573, objectId=667625e39e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=667625e39e, replyNumber=0, likeNumber=102, createdTime=2011-11-22, rootId=0, userName=醫(yī)生2394, userId=b505306, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=667625e39e, moduleTitle=肝母細胞瘤新輔助化療方案的治療效應(yīng)：形態(tài)學(xué)和免疫組織化學(xué)研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=667625e39e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
